PCM
KRMD icon

Prelude Capital Management’s KORU Medical Systems KRMD Stock Holding History

Prelude Capital Management’s Portfolio KRMD Stock Details KRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-400
Closed -$3K – 1754
2019
Q4 		$3K Buy
+400
New +$1.95K ﹤0.01% 1811

Other funds holding KRMD

HCM
Horton Capital Management Philadelphia, Pennsylvania $44.9M AUM 24.87% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
FA
Friess Associates Greenville, Delaware $59.9M AUM 3.42% 1-Year Est. Return
WT
Washington Trust Westerly, Rhode Island $2.96B AUM 22.49% 1-Year Est. Return
EGI
EAM Global Investors Solana Beach, California $47.1M AUM 320.45% 1-Year Est. Return

Prelude Capital Management's KRMD Position: Q1 2020 in Review

Prelude Capital Management sold out of KORU Medical Systems (KRMD) in Q1 2020, closing a stake of 400 shares — an estimated $3K sold.

Prelude Capital Management first reported a position in KRMD in Q4 2019 and held it in 1 quarter. The position peaked at $3K in Q4 2019. 55 funds tracked by Wall St. Rank hold KRMD as of Q1 2020.

  • Prelude Capital Management reported no remaining KORU Medical Systems position as of Q1 2020 after selling out during the quarter.
  • Prelude Capital Management sold 400 KORU Medical Systems shares in Q1 2020, an estimated $3K.
  • Prelude Capital Management first reported a position in KORU Medical Systems in Q4 2019 and held it in 1 quarter.
  • Prelude Capital Management's KORU Medical Systems position peaked at $3K in Q4 2019.
  • 55 funds tracked by Wall St. Rank held KORU Medical Systems as of Q1 2020.

Based on Prelude Capital Management's 13F filing for Q1 2020, filed 15 May 2020.